On June 4, UnitedHealth rose 3.17% in pre-market trading, trading at $388.32/share, with trading volume of $5.5612 million.
On the news front, Bank of America Securities upgraded UnitedHealth from Neutral to Buy, setting a target price of $450, implying approximately 16% upside from the current stock price. The upgrade comes amid a wave of bullish institutional sentiment, with multiple firms recently raising their targets on the stock. Truist raised its target price from $395 to $440 while maintaining a Buy rating, and Oppenheimer also lifted its target from $405 to $420. According to FactSet, the consensus analyst rating on UnitedHealth is Overweight, with a mean price target of $404.44.
Within the Managed Health Care sector where UnitedHealth belongs, among individual stocks, Elevance Health down 0.48%, Humana up 2.49%, Centene up 3.44%, Molina Healthcare up 0.98%, Alignment Healthcare up 1.05%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)